作者
Martin Hübner,Shigeki Kusamura,Laurent Villeneuve,Ahmed Al‐Niaimi,Mohammad Alyami,Konstantin Balonov,John Bell,Robert E. Bristow,Delia Cortés-Guiral,Anna Fagotti,Luiz Fernando R. Falcão,Olivier Gléhen,Laura Lambert,Lloyd A. Mack,Tino Muenster,Pompiliu Piso,Marc Pocard,Beate Rau,Olivia Sgarbură,S.P. Somashekhar,Anupama Wadhwa,Alon D. Altman,William Fawcett,Jula Veerapong,Gregg Nelson
摘要
BackgroundEnhanced recovery after surgery (ERAS) pathways have been shown to considerably reduce complications, length of stay and costs after most of surgical procedures by standardised application of best evidence-based perioperative care. The aim was to elaborate dedicated recommendations for cytoreductive surgery (CRS) ± hyperthermic intraperitoneal chemotherapy (HIPEC) in a two-part series of guidelines based on expert consensus. The present part II of the guidelines highlights postoperative management and special considerations.MethodsThe core group assembled a multidisciplinary panel of 24 experts involved in peritoneal surface malignancy surgery representing the fields of general surgery (n = 12), gynaecological surgery (n = 6), and anaesthesia (n = 6). Experts systematically reviewed and summarized the available evidence on 72 identified perioperative care items, following the GRADE (grading of recommendations, assessment, development, evaluation) system. Final consensus (defined as ≥50%, or ≥70% of weak/strong recommendations combined) was reached by a standardised 2-round Delphi process, regarding the strength of recommendations.ResultsResponse rates were 100% for both Delphi rounds. Quality of evidence was evaluated high, moderate low and very low, for 15 (21%), 26 (36%), 29 (40%) and 2 items, respectively. Consensus was reached for 71/72(98.6%) items. Strong recommendations were defined for 37 items. No consensus could be reached regarding the preemptive use of fresh frozen plasma.ConclusionThe present ERAS recommendations for CRS ± HIPEC are based on a standardised expert consensus process providing clinicians with valuable guidance. There is an urgent need to produce high quality studies for CRS ± HIPEC and to prospectively evaluate recommendations in clinical practice.